Docket Number:09A-980827
Inventor:Yaw-Huei Lin and Guan-Jhong Huang
IP Status:TW I419700、US pending
Abstract:
We evaluated the activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and antioxidant enzymes (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx)); contents of thiobarbituric acid reactive substances (TBARS), and glutathione (GSH), in mice injected with carbon tetrachloride (CCl4) without or with oral preadministration of IbTI. When mice were injected with CCl4 alone, the activities of ALT, AST, and the content of TBARS were increased, while the antioxidant enzyme activities were decreased. However, when the mice were injected with CCl4 with oral pretreatment of IbTI, the activities of ALT, AST, and TBARS content were significantly reduced and SOD, CAT, and GPx activities were remarkably increased. Histopathological studies of the liver of different groups also support the protective effects exhibited by IbTI. In addition, IbTI decreased the TNF-α level and increased the nitric oxide production in CCl4-injected mice.
Fields of Application:
Health maintenance: hepato-protection and anti-inflammation; or clinical application.
Advantages when compared to the existing technologies:
- IbTI is a rare multi-functional bioactive protein.
- We have both sources of obtaining easily large quantity of IbTI.
- No needs for toxicity and safety tests.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
